ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Alzheimers Dis Parkinsonism 2017, Vol 7(5): 380
  • DOI: 10.4172/2161-0460.1000380

A Novel TREM2-Mediated Link between Diabetes and Cognitive Impairment: Recent Findings and Future Perspectives

Masashi Tanaka, Hajime Yamakage, Takayuki Inoue, Shinya Masuda, Ryuji Ohue-Kitano, Toru Kusakabe and Noriko Satoh-Asahara*
Department of Endocrinology, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, , 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, Japan
*Corresponding Author : Noriko Satoh-Asahara, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1 Fukakusa Mukaihatacho, Fushimi-ku, Kyoto 612-8555, Japan, Tel: +81-75-641-9161, Fax: +81-75- 645-2781, Email: nsatoh@kuhp.kyoto-u.ac.jp

Received Date: Sep 25, 2017 / Accepted Date: Sep 26, 2017 / Published Date: Oct 03, 2017

Abstract

The protein triggering receptor expressed on myeloid cell 2 (TREM2) is a cell surface receptor exclusively expressed on microglia in the brain. Recent extensive studies reveal that the functions of TREM2 as well as the phenotypes of TREM2-expressing microglia are closely implicated in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease (AD), one of the most common causes of dementia. Furthermore, several recent studies reported a possible novel pathological implication for TREM2 in cognitive impairment associated with diabetes, one of the several metabolic diseases that are reported risk factors of dementia. In this review, we summarize recent advances and future research directions on the pathophysiological significance of TREM2 in AD and other neurodegenerative diseases as well as in metabolic diseases with increased risk for dementia.

Keywords: Alzheimer’s disease; Cognitive impairment; Diabetes; Metabolic disease; Microglia; Neurodegenerative disease; TREM2

Citation: Tanaka M, Yamakage H, Inoue T, Masuda S, Ohue-Kitano R, et al. (2017) A Novel TREM2-Mediated Link between Diabetes and Cognitive Impairment: Recent Findings and Future Perspectives. J Alzheimers Dis Parkinsonism 7: 380. Doi: 10.4172/2161-0460.1000380

Copyright: © 2017 Tanaka M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top